I never said company will fail. I said they will never be able to deliver consistent ROI and exit to investor via Big Pharma acquisition. They will remain a boutique outfit that no one cares about with dwindling valuation and endless dilution. It’s evident from the last 15 years. Those shareholders have been wiped off.
Also, evident from all the lies they have spewed over the years. Plus excuses, victim mindset, and blame game. Such outfits will never be successful. 5 years from data lock and all they can muster is an application to MHRA. No submission to EU or US or Canada. No reimbursement evidence submission in the UK either. All of this has been under their control but all they do is come up with lies and excuses. That ain’t changing going forward.
It’s also evident from their lack of or in fact no hiring in the UK when they are sitting on the cusp of approval. Very likely indicates they don’t expect significant upside in terms of revenue/volume or they don’t expect approval any time soon.
I also believe that the lawsuit will do more harm to shareholders than good. The market makers are not going to let it run even on the UK approval news. They will keep a tight lid on the share price and the shorts/hedge funds will pounce on any opportunity they get. These folks also know that LP is never going to get a big pharma or large, credible institutional investors to support NWBO. So endless dilution in pennies is inevitable with shady financiers who will continue to squeeze LP, just like the .22 dilution we saw last week or the week before.
AI
Market Data 
Markets 
